<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://173.199.123.204/Cysteinome/index.php?action=history&amp;feed=atom&amp;title=Thioredoxin</id>
		<title>Thioredoxin - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://173.199.123.204/Cysteinome/index.php?action=history&amp;feed=atom&amp;title=Thioredoxin"/>
		<link rel="alternate" type="text/html" href="http://173.199.123.204/Cysteinome/index.php?title=Thioredoxin&amp;action=history"/>
		<updated>2026-06-05T02:15:49Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.30.0</generator>

	<entry>
		<id>http://173.199.123.204/Cysteinome/index.php?title=Thioredoxin&amp;diff=1602&amp;oldid=prev</id>
		<title>Wu3857: /* Reference */</title>
		<link rel="alternate" type="text/html" href="http://173.199.123.204/Cysteinome/index.php?title=Thioredoxin&amp;diff=1602&amp;oldid=prev"/>
				<updated>2019-08-19T23:16:36Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Reference&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 23:16, 19 August 2019&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l40&quot; &gt;Line 40:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Reference==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Reference==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Bradshaw T D, Matthews C S, Cookson J, et al. '''Elucidation of thioredoxin as a molecular target for antitumor quinols[J].''' Cancer research, 2005, 65(9): 3911-3919. [https://www.ncbi.nlm.nih.gov/pubmed/?term=23441730 23441730]&amp;lt;br/&amp;gt;15867391 &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Bradshaw T D, Matthews C S, Cookson J, et al. '''Elucidation of thioredoxin as a molecular target for antitumor quinols[J].''' Cancer research, 2005, 65(9): 3911-3919. [https://www.ncbi.nlm.nih.gov/pubmed/?term=23441730 23441730]&amp;lt;br/&amp;gt;15867391 &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Ji W, Yang M, Praggastis A, et al. '''Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death[J].''' PloS one, 2014, 9(7): e103224. [https://www.ncbi.nlm.nih.gov/pubmed/?term=&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;23441730 23441730&lt;/del&gt;]&amp;lt;br/&amp;gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;25068797 &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;# Ji W, Yang M, Praggastis A, et al. '''Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death[J].''' PloS one, 2014, 9(7): e103224. [https://www.ncbi.nlm.nih.gov/pubmed/?term=&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;25068797 25068797&lt;/ins&gt;]&amp;lt;br/&amp;gt; &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Targets|&lt;/del&gt;Targets]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Targets]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Homo sapiens|&lt;/del&gt;Homo sapiens]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Homo sapiens]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Redox protein|&lt;/del&gt;Redox protein]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Redox protein]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Thioredoxin family|&lt;/del&gt;Thioredoxin family]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Thioredoxin family]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;NOD-like receptor signaling pathway|&lt;/del&gt;NOD-like receptor signaling pathway]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:NOD-like receptor signaling pathway]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Fluid shear stress and atherosclerosis|&lt;/del&gt;Fluid shear stress and atherosclerosis]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Fluid shear stress and atherosclerosis]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Wu3857</name></author>	</entry>

	<entry>
		<id>http://173.199.123.204/Cysteinome/index.php?title=Thioredoxin&amp;diff=991&amp;oldid=prev</id>
		<title>Wu3857: Created page with &quot;{| align=&quot;left&quot;   | __TOC__   |} {{#invoke:InfoboxforTarget|run|Trx, TRDX, TXN|[https://www.uniprot.org/uniprot/P10599 P10599]|Homo sapiens|Cys32, Cys35|[http://pfam.xfam.org/...&quot;</title>
		<link rel="alternate" type="text/html" href="http://173.199.123.204/Cysteinome/index.php?title=Thioredoxin&amp;diff=991&amp;oldid=prev"/>
				<updated>2019-08-04T01:47:38Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;{| align=&amp;quot;left&amp;quot;   | __TOC__   |} {{#invoke:InfoboxforTarget|run|Trx, TRDX, TXN|[https://www.uniprot.org/uniprot/P10599 P10599]|Homo sapiens|Cys32, Cys35|[http://pfam.xfam.org/...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| align=&amp;quot;left&amp;quot;&lt;br /&gt;
  | __TOC__&lt;br /&gt;
  |}&lt;br /&gt;
{{#invoke:InfoboxforTarget|run|Trx, TRDX, TXN|[https://www.uniprot.org/uniprot/P10599 P10599]|Homo sapiens|Cys32, Cys35|[http://pfam.xfam.org/family/PF00085 Thioredoxin family]|[[:Category:Thioredoxin|Ligand list]]|Redox protein}}&lt;br /&gt;
==Summary==&lt;br /&gt;
&lt;br /&gt;
===Protein Function ===&lt;br /&gt;
Thioredoxin is a class of small redox proteins known to be present in all organisms. It plays a role in many important biological processes, including redox signaling. In humans, thioredoxins are encoded by TXN and TXN2 genes. Loss-of-function mutation of either of the two human thioredoxin genes is lethal at the four-cell stage of the developing embryo. Although not entirely understood, thioredoxin plays a central role in humans and is increasingly linked to medicine through their response to reactive oxygen species (ROS). (From Wikipedia) &amp;lt;br/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Cys Function &amp;amp; Property===&lt;br /&gt;
Cys32 and Cys35 are quite close to the active site of Trx, which could form disulfide bond or free state under differrent situtation.&amp;lt;br/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* Hydrophobic property:&lt;br /&gt;
:[[File:526-hydro.png||600px]]&lt;br /&gt;
* SASA：&lt;br /&gt;
:Cys32: 7.575 A^2&lt;br /&gt;
:Cys35: 4.701 A^2&lt;br /&gt;
&lt;br /&gt;
==Protein Sequence==&lt;br /&gt;
&amp;lt;font face=&amp;quot;Courier&amp;quot;&amp;gt;&lt;br /&gt;
MVKQIESKTA FQEALDAAGD KLVVVDFSAT W&amp;lt;span style=&amp;quot;background:#ffff00&amp;quot;&amp;gt;'''C'''&amp;lt;/span&amp;gt;GP&amp;lt;span style=&amp;quot;background:#ffff00&amp;quot;&amp;gt;'''C'''&amp;lt;/span&amp;gt;KMIKP FFHSLSEKYS &amp;lt;br/&amp;gt;&lt;br /&gt;
NVIFLEVDVD DCQDVASECE VKCMPTFQFF KKGQKVGEFS GANKEKLEAT &amp;lt;br/&amp;gt;&lt;br /&gt;
INELV &amp;lt;br/&amp;gt; &lt;br /&gt;
&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Structural Information==&lt;br /&gt;
*Known structures with covalent ligands: &amp;lt;br/&amp;gt;&lt;br /&gt;
:Unknown&amp;lt;br/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Protein structure:&lt;br /&gt;
[[File:526.png|center|800px]]&lt;br /&gt;
&lt;br /&gt;
==Related Pathway==&lt;br /&gt;
*[https://www.genome.jp/kegg-bin/show_pathway?ko04621 NOD-like receptor signaling pathway] &amp;lt;br/&amp;gt;&lt;br /&gt;
*[https://www.genome.jp/kegg-bin/show_pathway?ko05418 Fluid shear stress and atherosclerosis] &amp;lt;br/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Experimental Evidence==&lt;br /&gt;
:MS/MS spectra, Tryptic Digest, Cys-directed Mutation  &lt;br /&gt;
&lt;br /&gt;
==Reference==&lt;br /&gt;
# Bradshaw T D, Matthews C S, Cookson J, et al. '''Elucidation of thioredoxin as a molecular target for antitumor quinols[J].''' Cancer research, 2005, 65(9): 3911-3919. [https://www.ncbi.nlm.nih.gov/pubmed/?term=23441730 23441730]&amp;lt;br/&amp;gt;15867391 &lt;br /&gt;
# Ji W, Yang M, Praggastis A, et al. '''Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death[J].''' PloS one, 2014, 9(7): e103224. [https://www.ncbi.nlm.nih.gov/pubmed/?term=23441730 23441730]&amp;lt;br/&amp;gt;25068797 &lt;br /&gt;
&lt;br /&gt;
[[Category:Targets|Targets]]&lt;br /&gt;
[[Category:Homo sapiens|Homo sapiens]]&lt;br /&gt;
[[Category:Redox protein|Redox protein]]&lt;br /&gt;
[[Category:Thioredoxin family|Thioredoxin family]]&lt;br /&gt;
[[Category:NOD-like receptor signaling pathway|NOD-like receptor signaling pathway]]&lt;br /&gt;
[[Category:Fluid shear stress and atherosclerosis|Fluid shear stress and atherosclerosis]]&lt;/div&gt;</summary>
		<author><name>Wu3857</name></author>	</entry>

	</feed>